Pathology Lectures

Cystic Fibrosis Mucoviscidosis

68 slides · PPTX & PDF available

Download PDF
Request PowerPoint

PowerPoint animations are preserved in the original file.

Marks are temporary. Tap a drawing tool again to stop.
Slide index (68)
  1. Loading slide titles…

Loading presentation…

Swipe on touchscreens · Use ← / → to change slides, Home / End to jump.

Lecture topics

Slide index & full transcript (68 slides)

Text from the original slides, in presentation order. Diagrams and images remain in the viewer above.

Slide 1 · Cystic Fibrosis (Mucoviscidosis)

Molecular mechanism · organ pathology · clinicopathologic diagnosis

Pathology lecture

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning outcomes

Explain how CFTR dysfunction alters epithelial ion and fluid transport.

Relate viscous secretions to structural injury in lung, pancreas, intestine, and hepatobiliary tract.

Recognize the clinical spectrum, diagnostic logic, and genotype-dependent variation.

Distinguish supportive care from mechanistically targeted CFTR treatments.

Slide 3 · A single-gene disorder with multisystem consequences

Autosomal recessive disorder of epithelial ion transport.

Affects exocrine glands and respiratory, gastrointestinal, and reproductive epithelia.

Thickened secretions obstruct ducts and airways.

Clinical effects arise from obstruction, infection, inflammation, and impaired secretion.

CFTR dysfunction

Altered salt + water movement

Multiorgan complications

Slide 4 · Why “mucoviscidosis” describes the phenotype

Viscous, poorly hydrated secretions accumulate within epithelial passages.

Mechanical obstruction compromises secretion drainage.

Retained secretions predispose to inflammation and secondary infection.

Manifestations depend on which ductal system is affected.

Altered epithelial fluids

Luminal plugging

Secondary organ injury

Slide 5 · Clinical expression is heterogeneous

Onset ranges from prenatal or neonatal disease to childhood, adolescence, and adulthood.

Some individuals present with classic multisystem disease.

Others exhibit comparatively mild or organ-limited manifestations.

Variation reflects CFTR alleles, tissue physiology, and modifier effects.

Classic CF

Pancreas-sufficient CF

Late-onset pulmonary disease

Isolated reproductive phenotype

Slide 6 · Transmission follows an autosomal recessive pattern

Two parental CFTR alleles

Biallelic pathogenic variants

Reduced epithelial CFTR function

Characteristic organ phenotypes

Affected individuals carry disease-causing variants in both alleles.

Different variant combinations alter residual CFTR function and the clinical phenotype.

Slide 7 · Historical epidemiologic context

An incidence of approximately 1 in 2,500 live births among people of Northern European descent.

The source reports a U.S. Carrier frequency of approximately 1 in 20 in that ancestry group.

CFTR variants occur globally, with substantial population differences.

These textbook figures are ancestry-specific historical estimates, not universal contemporary rates.

Slide 8 · One molecular defect, different tissue responses

Respiratory / intestinal epithelium

Reduced anion secretion

Dehydrated surface fluid

Mucus stasis and obstruction

Sweat duct epithelium

Reduced salt reabsorption

Excess NaCl remains in sweat

High sweat chloride

Slide 9 · CFTR is an epithelial anion channel

CFTR gene is located on chromosome 7q31.2.

The encoded protein forms an apical membrane ion channel.

Its primary relevant substrates are chloride and bicarbonate ions.

It also regulates interacting ion channels and secretory processes.

Schematic: Apical membrane

Lumen

CFTR

Cytoplasm

Cl⁻ / HCO₃⁻ secretion

Transport directed toward the lumen

Slide 10 · The CFTR protein has modular architecture

Two membrane-spanning domains

Two nucleotide-binding domains

Regulatory (R) domain

The membrane domains form the ion-conducting pore.

ATP handling at nucleotide-binding domains controls channel gating.

Phosphorylation of the R domain promotes channel opening.

Slide 11 · Cyclic AMP controls channel activation

Agonist → ↑ cAMP

Protein kinase A activation

R-domain phosphorylation

ATP-dependent channel gating

The channel is not a permanently open hole; Regulatory signals coordinate its operation.

Disruptions in gating can cause disease even if the protein reaches the membrane.

Slide 12 · Chloride transport is not the only CFTR function

CFTR conducts HCO₃⁻ as well as Cl⁻.

It interacts with epithelial sodium channel (ENaC).

CFTR-linked transport helps set the hydration and chemistry of surface secretions.

Abnormal bicarbonate transport favors acidic, poorly soluble mucus.

Schematic: Apical membrane

Lumen

CFTR

Cytoplasm

Cl⁻ / HCO₃⁻ secretion

Transport directed toward the lumen

Slide 13 · Normal airway fluid supports mucociliary clearance

Apical anion secretion

Appropriate surface water layer

Cilia mobilize mucus

Microorganisms are cleared

Water content and ciliary movement cooperate to clear inhaled material.

The airway surface fluid layer is physiologically important even when its salt concentration is unchanged.

Slide 14 · CF airways lose surface-fluid volume

↓ Cl⁻ secretion

↑ ENaC-mediated Na⁺ uptake

↑ passive water reabsorption

Dehydrated airway secretions

An isotonic but low-volume airway surface layer.

The dominant physiologic lesion is dehydration of mucus, not simply excessive airway salt concentration.

Slide 15 · Airway mucus becomes difficult to clear

Water loss concentrates airway mucus.

Ciliary activity becomes ineffective against dense secretions.

Mucus obstructs bronchi and bronchioles.

Stagnant secretions facilitate bacterial persistence.

Schematic bronchial lumen

Inspissated mucus

Obstruction + infection

Slide 16 · The sweat duct behaves in the opposite direction

Normal sweat ducts reabsorb luminal chloride and associated sodium.

CFTR dysfunction reduces ductal NaCl reclamation.

Sweat therefore contains increased electrolyte concentrations.

Sweat glands show no characteristic structural abnormality despite the transport defect.

Schematic: Sweat duct lumen

Na⁺ + Cl⁻ stay in lumen

Elevated sweat salt

Normal gland morphology

Slide 17 · Bicarbonate defects promote ductal plugging

↓ HCO₃⁻ transport

Lower ductal secretion pH

Increased mucin precipitation

Obstructed exocrine ducts

CFTR interacts with SLC26-family anion exchangers.

Some variants preserve chloride transport relatively well while markedly disrupting bicarbonate transport.

Slide 18 · Salt elevation and mucus dehydration are not contradictions

Sweat duct

Normal role: Electrolyte reabsorption

CF: NaCl remains in the lumen

Phenotype: Salty sweat

Airway / intestine

Normal role: Luminal anion secretion

CF: Water depleted from luminal fluid

Phenotype: Thickened secretions

Slide 19 · Different organs share a duct-obstruction mechanism

Defective epithelial anion transport

Abnormal luminal secretions

Ductal / airway plugging

Atrophy, infection, or fibrosis

The final tissue response depends on local anatomy and function.

Some tissues primarily develop destructive inflammation; Others lose secretory parenchyma.

Slide 20 · More than one molecular mechanism causes CF

Variants alter the amount, localization, gating, conductance, or stability of CFTR.

The source describes six functional mutation classes.

Different classes leave different amounts of residual channel activity.

Functional classes explain disease mechanisms but do not fully predict severity in every organ.

Absent synthesis

Misfolding / trafficking

Gating failure

Reduced channel activity

Slide 21 · Classes I–III: Severe reduction in function

Class

Principal defect

Consequences

I

No protein synthesis

No apical CFTR

II

Misfolding / trafficking

Degradation before surface delivery

III

Defective gating

Membrane protein with poor opening

Slide 22 · Classes IV–VI: Residual or unstable function

Class

Principal defect

Consequences

IV

Reduced conductance

Reduced ion flow through pore

V

Reduced production

Decreased amount of near-normal CFTR

VI

Membrane instability

Accelerated loss from surface

Slide 23 · Phe508del illustrates defective processing

Deletion of Phe508

Impaired folding of CFTR

Retention / degradation

Near-absent surface CFTR

Also historically written ΔF508; It is a class II processing variant.

Protein quantity at the membrane falls because of impaired maturation and trafficking.

Slide 24 · Gating and conductance are distinct failures

Class III: Gating

Protein may reach apical surface

Opening response is defective

Example in source: Gly551Asp

Class IV: Conductance

Protein may reach apical surface

Ion flux through open pore is reduced

Example in source: Arg117His

Slide 25 · Genotype predicts pancreatic disease better than lung disease

Two severely impaired alleles commonly produce pancreatic-insufficient classic CF.

One allele with residual function may preserve exocrine pancreatic output.

Pulmonary severity depends more heavily on environmental and genetic modifiers.

Identical CFTR genotypes need not produce identical pulmonary trajectories.

CFTR genotype

Residual channel function

Tissue-specific phenotype

Slide 26 · Modifier effects broaden the phenotype

CFTR variants

Modifier loci

Environmental exposures

Observed disease severity

MBL2, TGFB1, and IFRD1 as example modifier loci.

Intercurrent viral and chronic bacterial infections influence lung disease progression.

Slide 27 · The lung develops a self-perpetuating injury cycle

Mucus retention

Airway bacterial persistence

Inflammation and tissue injury

Worsening clearance

Obstructed airways create conditions that favor further infection.

Inflammatory damage can amplify obstruction and chronic structural lung disease.

Slide 28 · Chronic infection is not just an acute exacerbation

Impaired clearance permits intermittent and then chronic colonization.

Pseudomonas aeruginosa is particularly important in progressive lung disease.

Persistent organisms may establish biofilms that resist host defense.

Recurrent infection and inflammation ultimately distort airway architecture.

Impaired clearance

Chronic colonization

Bronchiectasis / damage

Slide 29 · Pseudomonas biofilm impedes clearance

Stagnant hypoxic mucus

Alginate production

Mucoid bacterial biofilm

Protected persistence

The alginate-rich phenotype is associated with chronic infection.

Host antibody and cellular responses may add injury without eliminating embedded bacteria.

Slide 30 · Airway pathogens have clinical significance

Organism

Pathologic significance

Staphylococcus aureus

Recurrent airway infection

Haemophilus influenzae

Recurrent airway infection

Pseudomonas aeruginosa

Mucoid chronic colonization; biofilm

Burkholderia cepacia complex

Potential severe progressive infection

Slide 31 · Other respiratory complications extend the differential

Robbins also identifies Stenotrophomonas maltophilia and nontuberculous mycobacteria as opportunistic pathogens.

Allergic bronchopulmonary aspergillosis occurs with increased frequency.

Burkholderia cenocepacia may cause severe illness within the B. Cepacia complex.

Microbiology must be interpreted with the chronic bronchiectatic setting in mind.

Slide 32 · Early pulmonary morphology: Impacted bronchioles

Thick mucus distends the bronchiolar lumen.

Mucus-producing epithelial cells undergo hypertrophy and hyperplasia.

Luminal obstruction impairs distal ventilation and clearance.

Secondary infection intensifies epithelial and tissue injury.

Schematic bronchial lumen

Inspissated mucus

Obstruction + infection

Slide 33 · Advanced pulmonary morphology: Bronchiectasis

Chronic mucus plugging

Neutrophilic / infectious injury

Airway wall destruction

Permanent bronchial dilation

The text describes chronic bronchitis, bronchiectasis, and sometimes lung abscesses.

Anatomical damage becomes an independent obstacle to effective clearance.

Slide 34 · Pulmonary findings connect mechanism to symptoms

Mechanism / lesion

Clinical association

Mucus plugging

Chronic cough, sputum, wheezing

Airway obstruction

Air trapping, hyperinflation

Bronchiectasis / infection

Persistent radiographic changes

Chronic pulmonary disease

Clubbing, cardiopulmonary complications

Slide 35 · Sinus disease belongs to the CF phenotype

Chronic sinonasal disease is a characteristic extrapulmonary airway manifestation.

Nasal polyps are included among recognized clinical features.

Persistent sinus abnormalities can coexist with bronchial disease.

Organ-specific symptoms may precede recognition of multisystem CF.

Chronic sinusitis

Nasal polyps

Bronchiectasis

Airway infections

Slide 36 · Pulmonary disease drives major late complications

Chronic airway injury

Obstructive lung disease

Pulmonary vascular strain

Cor pulmonale

The text identifies cardiorespiratory complications as a major cause of mortality.

Lung disease severity is influenced by organisms, host inflammation, and modifiers.

Slide 37 · The pancreas is frequently structurally involved

Pancreatic lesions occur in most individuals with classic CF.

Mild involvement may begin as mucus accumulation and duct dilation.

Severe lesions show acinar destruction and progressive fibrosis.

At an advanced stage, islets may persist within fibrofatty stroma.

Schematic: Exocrine pancreas

Mucus-filled ducts → acinar loss

Fibrofatty replacement

Slide 38 · How duct obstruction destroys the exocrine pancreas

Thick intraductal secretions

Outflow obstruction

Acinar atrophy / loss

Fibrofatty replacement

Impaired enzyme delivery contributes to malabsorption.

Morphologic severity varies markedly across CFTR genotypes.

Slide 39 · Pancreatic insufficiency impairs nutrient absorption

Reduced exocrine enzymes

Fat and protein maldigestion

Steatorrhea / nutritional losses

Poor weight gain

Large, foul-smelling stools and abdominal distention may begin during infancy.

Pancreatic disease explains much of the failure-to-thrive phenotype.

Slide 40 · Fat-soluble vitamin deficiencies are predictable

Deficiency

Clinicopathologic significance

Vitamin A

Deficiency may contribute to epithelial changes

Vitamin D

Reduced fat-soluble vitamin availability

Vitamin E

Vitamin depletion with chronic malabsorption

Vitamin K

Vitamin depletion with chronic malabsorption

Slide 41 · Not every patient requires pancreatic enzymes

Pancreatic-insufficient CF

Often two severe alleles

Steatorrhea / failure to thrive

Substantial acinar destruction

Pancreas-sufficient CF

Residual CFTR activity may persist

Better growth and absorption

Pancreatitis may still occur

Slide 42 · Pancreatitis can signal less complete CFTR loss

Some pancreas-sufficient individuals develop recurrent pancreatitis.

Recurrent episodes may manifest with acute abdominal pain.

CFTR-associated chronic pancreatitis may occur without classic multisystem CF.

Interpret isolated pancreatic disease in the context of genotype and physiology.

Residual duct function

Recurrent pancreatic injury

Pancreatitis phenotype

Slide 43 · Pancreatic injury may also affect islet function

Progressive parenchymal destruction can involve the endocrine pancreas.

Cystic-fibrosis-related diabetes occurs in a subset of affected adults.

Exocrine insufficiency and endocrine dysfunction are related but distinct consequences.

The clinical presentation depends on extent and duration of pancreatic injury.

Schematic: Exocrine pancreas

Mucus-filled ducts → acinar loss

Fibrofatty replacement

Slide 44 · Meconium ileus is an early diagnostic clue

Abnormal intestinal secretion

Inspissated meconium

Small-bowel obstruction

Neonatal presentation

Neonatal meconium ileus as an initial presentation in a minority of cases.

The obstruction is a consequence of abnormal luminal secretions, not a primary muscle disorder.

Slide 45 · Distal intestinal obstruction can recur later

Older patients may have episodes of distal intestinal obstruction syndrome.

A typical syndrome includes right lower quadrant pain.

A palpable meconium mass may be present in the right iliac fossa.

Intussusception can occur in association with obstruction.

Thick intestinal contents

Distal bowel obstruction

Right iliac fossa symptoms

Slide 46 · Additional gastrointestinal manifestations

Persistent malabsorptive diarrhea may contribute to rectal prolapse.

Loss of protein can cause marked hypoproteinemia and generalized edema.

Intestinal phenotypes are most pronounced when pancreatic exocrine secretion is inadequate.

Relatively pancreas-sufficient individuals often have better nutritional outcomes.

Slide 47 · CF hepatobiliary disease begins with secretion obstruction

Thick bile / ductal plugging

Ductular proliferation

Portal inflammation

Focal biliary fibrosis

Hepatic steatosis may coexist.

A subset progresses to focal or diffuse biliary cirrhosis.

Slide 48 · Cystic fibrosis liver disease is variable

Focal biliary cirrhosis may arise after chronic biliary injury.

Severe diffuse cirrhotic disease affects a minority of patients.

Clinical or biochemical liver abnormalities may emerge later in life.

Bile-duct sludge or stones can produce acute pain and jaundice.

Biliary duct plugging

Portal fibrosis

Cirrhosis in a subset

Slide 49 · Salivary gland changes resemble pancreatic changes

Ductal mucus retention

Duct dilation

Epithelial metaplasia

Gland atrophy and fibrosis

Squamous metaplasia of ductal epithelial lining.

Shared ductal anatomy explains similar injury responses in multiple exocrine glands.

Slide 50 · Male reproductive findings can dominate presentation

Congenital bilateral absence of the vas deferens is characteristic.

Obstructive azoospermia causes infertility in most affected adult males.

In some individuals this may be the only clinical indication of a CFTR-associated disorder.

An otherwise limited reproductive phenotype does not exclude CFTR variants.

CFTR variants

Vas deferens abnormality

Obstructive azoospermia

Slide 51 · Classic versus nonclassic cystic fibrosis

Classic phenotype

Sinopulmonary involvement

Pancreatic insufficiency common

Multiorgan features often coexist

Nonclassic phenotype

Later or limited presentation

Residual CFTR function often present

May involve pancreas, lung, or vas deferens

Slide 52 · Common clinical feature clusters

System

Findings in Robbins

Airways

Chronic cough, sputum, infections, bronchiectasis

GI / nutrition

Meconium ileus, steatorrhea, poor growth

Hepatobiliary

Chronic liver disease or biliary cirrhosis

Sweat / salt

Elevated sweat chloride; salt depletion

Reproduction

Congenital bilateral absent vas deferens

Slide 53 · Clinical suspicion arises from phenotype or screening

Typical clinical feature

Family history / relative

Newborn screen positive

Confirm CFTR dysfunction

Characteristic multisystem findings raise pretest probability.

A positive screen is an entry point for confirmation, not a final diagnosis.

Slide 54 · Newborn screening measures pancreatic injury

Immunoreactive trypsinogen in blood as a common screening analyte.

Pancreatic injury may elevate the measured concentration.

A positive result requires appropriate confirmatory testing.

Screening assesses risk; It does not directly prove altered epithelial ion transport.

Raised IRT screen

Clinical follow-up

Confirmatory CF testing

Slide 55 · Sweat chloride reflects duct transport physiology

Loss of CFTR-mediated salt reclamation raises sweat NaCl.

The sweat test is grounded in a disease-specific transport defect.

Textbook diagnostic criteria combine phenotype/screening with objective CFTR dysfunction.

Atypical variants may yield borderline or near-normal sweat concentrations.

Schematic: Sweat duct lumen

Na⁺ + Cl⁻ stay in lumen

Elevated sweat salt

Normal gland morphology

Slide 56 · Diagnostic evidence has complementary roles

Approach

What it contributes

Clinical phenotype / family

Raises suspicion or pretest probability

Immunoreactive trypsinogen

Newborn screening signal

Sweat chloride

Evidence of impaired sweat-duct ion transport

CFTR variant analysis

Identification of disease-causing variants

Functional electrophysiology

Nasal or intestinal CFTR functional evidence

Slide 57 · Interpret intermediate or discordant tests cautiously

Suggestive history / screen

Sweat chloride assessment

Genetic evaluation

Functional tests if needed

Robbins reproduces a diagnostic framework allowing complementary evidence.

Do not assume that all CFTR sequence variants are disease-causing or that one normal test rules out atypical disease.

Slide 58 · Molecular therapy targets the causal protein defect

Conventional treatment addresses infection, nutrition, and organ complications.

CFTR-directed therapies act on the protein itself.

Eligibility depends on disease-causing variant and molecular behavior.

Robbins groups CFTR agents into potentiators, correctors, and amplifiers.

CFTR defect

Mutation-matched approach

Improved protein function

Slide 59 · Potentiators versus correctors

Potentiators

Improve channel opening

Especially relevant to gating defects

Require surface-available CFTR

Correctors

Support folding / processing

Increase membrane CFTR delivery

Relevant to processing defects

Slide 60 · Amplifiers represent a different intervention point

CFTR gene expression

CFTR protein abundance

Function at cell surface

Epithelial ion transport

Amplifiers as agents intended to increase CFTR protein production.

More protein alone may not repair a defective gating or trafficking mechanism.

Slide 61 · Supportive treatment remains organ-directed

Clinical problem

Management strategy described

Recurrent airway infection

Antimicrobial therapy

Pancreatic insufficiency

Pancreatic enzyme replacement

Severe end-stage lung disease

Bilateral lung transplantation

Specific CFTR variants

Targeted modulator combination therapy

Slide 62 · Integrated case: Neonatal obstruction

Clinical problem

A newborn develops intestinal obstruction from unusually thick meconium.

The family reports unusually salty sweat in an affected sibling.

Consider how an epithelial transport defect could explain both findings.

Mechanistic interpretation

Meconium ileus suggests intestinal secretion abnormality; Defective sweat-duct salt reabsorption provides the parallel diagnostic clue.

Slide 63 · Integrated case: Recurrent pulmonary infection

Clinical problem

An adolescent has productive cough, recurrent infections, and bronchiectasis.

Airway cultures repeatedly yield mucoid Pseudomonas aeruginosa.

Explain how impaired CFTR function favors this chronic infection pattern.

Mechanistic interpretation

A dehydrated mucus layer impairs clearance; Stagnant hypoxic secretions favor alginate-rich biofilm and ongoing airway damage.

Slide 64 · Integrated case: Pancreatic-sufficient phenotype

Clinical problem

An adult has recurrent idiopathic pancreatitis and no prominent steatorrhea.

CFTR-related disease is considered despite relatively preserved nutrition.

Explain why a milder or organ-limited CFTR phenotype is plausible.

Mechanistic interpretation

Residual channel function may preserve exocrine output while permitting episodic ductal injury; Pulmonary and pancreatic severity need not parallel each other.

Slide 65 · Four causal links explain the clinical syndrome

CFTR ion transport

Secretion hydration / pH

Obstruction and infection

Organ failure phenotype

The same mutation can produce contrasting sweat and airway electrolyte effects.

Pulmonary, pancreatic, biliary, intestinal, and reproductive lesions follow tissue-specific consequences.

Slide 66 · Pathology synthesis

Respiratory tract: Mucus plugging, chronic infection, bronchiectasis, and pulmonary complications.

Pancreas: Ductal obstruction, exocrine acinar loss, fibrosis, and malabsorption.

Intestine and biliary tree: Thick secretions, obstruction, and possible progressive liver injury.

Reproductive tract: Congenital bilateral absence of vas deferens and obstructive azoospermia.

Sweat glands: Characteristic functional electrolyte defect without structural lesion.

Slide 67 · Diagnostic synthesis and clinical reasoning

Recognize a constellation of sinopulmonary disease, pancreatic or intestinal disease, and characteristic reproductive findings.

Use newborn screening or phenotype to initiate—not conclude—diagnosis.

Confirm CFTR dysfunction through complementary sweat, molecular, or epithelial functional evidence.

Relate phenotype to residual CFTR function, tissue physiology, and modifier effects.

Slide 68 · Source and scope

Principal textbook

Robbins, Cotran & Kumar: Pathologic Basis of Disease

11th edition (2026) · Diseases of Infancy and Childhood

Cystic Fibrosis and adjacent CFTR mechanism, morphology, and clinical-feature sections

The presentation uses original editable schematics. No textbook micrographs or scanned textbook figures are reproduced.

Privacy preferences

Essential storage remembers your theme and privacy choice. Secure forms and teaching requests remain available whichever option you choose.

Teaching activity uses separate aggregate counters and short-lived sessions. SlideShare links open the original presentations on SlideShare. Form security checks are provided by third parties.

No message text, email addresses, visitor identifiers, or destination URLs are included in optional measurement. Read privacy details